Details
- Status
- Closed
- Opening date
- Deadline
Target audience
The call is open to those developing novel vaccines or novel vaccine technologies both inside and outside the EU/EEA.
Why we are consulting
HERA is organising a virtual workshop to discuss next generation vaccines. The workshop will bring together scientists, industry, and national authorities.
The objective of the meeting is to showcase current work towards the development of innovative vaccines, in particular a new generation of COVID-19 vaccines, that offer broad-spectrum protection, confer long-lasting immunity, use innovative and advantageous modes of administration and delivery, or could potentially contribute to greater global vaccine equity. HERA aims to draw on this workshop in developing their work identifying promising vaccine candidates and technological developments, which could be the subject of future funding calls or procurement activities.
The draft agenda is outlined below:
- Welcome
- Session 1: New science and technologies for vaccines
- Session 2: Presentations by vaccine developers
- Session 3: Presentations by Member States
- Closing remarks
We are inviting relevant stakeholders, in particular vaccine and biotech companies, who are developing vaccines with promising products or innovations to give short presentations of their products under development in Session 2.